Selected article for: "aat short peptide reversible chymotrypsin inhibitor and aberrant form"

Author: Su, Junhui; Chang, Cui; Xiang, Qi; Zhou, Zhi-Wei; Luo, Rong; Yang, Lun; He, Zhi-Xu; Yang, Hongtu; Li, Jianan; Bei, Yu; Xu, Jinmei; Zhang, Minjing; Zhang, Qihao; Su, Zhijian; Huang, Yadong; Pang, Jiyan; Zhou, Shu-Feng
Title: Xyloketal B, a marine compound, acts on a network of molecular proteins and regulates the activity and expression of rat cytochrome P450 3a: a bioinformatic and animal study
  • Document date: 2014_12_12
  • ID: y14atmnh_70
    Snippet: Inhibitor of serine proteases. Its primary target is elastase, but it also has a moderate affinity for plasmin and thrombin. Irreversibly inhibits trypsin, chymotrypsin, and plasminogen activator. The aberrant form inhibits insulin-induced nitric oxide synthesis in platelets, decreases coagulation time, and has proteolytic activity against insulin and plasmin. Short peptide from AAT is a reversible chymotrypsin inhibitor. It also inhibits elastas.....
    Document: Inhibitor of serine proteases. Its primary target is elastase, but it also has a moderate affinity for plasmin and thrombin. Irreversibly inhibits trypsin, chymotrypsin, and plasminogen activator. The aberrant form inhibits insulin-induced nitric oxide synthesis in platelets, decreases coagulation time, and has proteolytic activity against insulin and plasmin. Short peptide from AAT is a reversible chymotrypsin inhibitor. It also inhibits elastase, but not trypsin. Its major physiological function is the protection of the lower respiratory tract against proteolytic destruction by human leukocyte elastase. showing the greater ability to mobilize cytoplasmic calcium in comparison to isoform 1. Required in brain development and mature brain function with important roles in the regulation of axon growth, axon guidance, and neurite extension. Blocks axon out growth and attraction induced by NTN1 by phosphorylating its receptor DDC.

    Search related documents:
    Co phrase search for related documents
    • AAT short peptide and chymotrypsin inhibitor: 1
    • AAT short peptide and coagulation time: 1
    • AAT short peptide and human leukocyte elastase: 1
    • aberrant form and chymotrypsin inhibitor: 1
    • aberrant form and coagulation time: 1
    • aberrant form and human leukocyte elastase: 1
    • axon guidance and important role: 1
    • brain development and important role: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • brain function and important role: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
    • chymotrypsin inhibitor and coagulation time: 1
    • chymotrypsin inhibitor and human leukocyte elastase: 1
    • coagulation time and human leukocyte elastase: 1
    • coagulation time and important role: 1, 2, 3
    • great ability and important role: 1